📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-26 18:29
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
28 announcements match the current filters (relevance ≥ 5).
Deepak Nitrite and DPL Infuse ₹175 Cr in Subsidiary Deepak Chem Tech via 9% OCRPS
Deepak Nitrite Limited (DNL) and its wholly owned subsidiary Deepak Phenolics Limited (DPL) have infused a total of ₹175 Crore into Deepak Chem Tech Limited (DCTL) via 9% Optionally Convertible Redeemable Preference Shares (OCRPS). DNL subscribed to 80 lakh shares (₹80 Crore) while DPL subscribed to 95 lakh shares (₹95 Crore) at ₹100 par value. The capital will support DCTL's ongoing project expenses and general corporate purposes across its chemical plants in Gujarat. DCTL has scaled its turnover rapidly from ₹0.86 Crore in FY24 to ₹172.23 Crore in FY26.
Confidence: HIGH
What changedDNL and DPL completed an internal capital infusion of ₹175 Crore into wholly owned subsidiary DCTL via 9% OCRPS.
Why it mattersProvides necessary funding to scale DCTL's specialty downstream projects without increasing consolidated external debt.
Total Infusion Amount: ₹175 CroresDNL Direct Infusion: ₹80 CroresDPL Infusion: ₹95 CroresDCTL FY26 Turnover: ₹172.23 CroresInfusion vs TTM Revenue: ~2.0%
📅 Short termNeutral; this is an internal group restructuring/funding event with no immediate impact on consolidated quarterly earnings.
📈 Long termSupports DNL's strategic vertical integration into advanced intermediates and downstream chemistries to diversify away from commodity cycles.
⚠ Risk flags
- Project execution timelines and ramp-up risks at DCTL's Gujarat manufacturing sites.
Key Highlights
DNL and DPL infused ₹80 Crore and ₹95 Crore respectively, totaling ₹175 Crore into DCTL.
Allotment consists of 1.75 Crore 9% OCRPS with a face value of ₹100 each issued at par.
DCTL turnover grew to ₹172.23 Crore in FY26, up from ₹9.43 Crore in FY25 and ₹0.86 Crore in FY24.
Pre-allotment paid-up capital of DCTL stood at ₹2,744.5 Crore (₹499.5 Crore equity and ₹2,245 Crore preference shares).
👀 What to Watch
Track the commercialization and revenue ramp-up of DCTL's fluorination, nitric acid, nitration, and hydrogenation projects in upcoming quarterly updates.
₹2,592 Cr Revenue: Deepak Nitrite Reports Record Q1 FY27 Performance and New Project Commissioning
Deepak Nitrite reported a record-breaking Q1 FY27 with consolidated revenue of ₹2,592 crore, a 35% YoY increase. EBITDA margins expanded significantly to 21% from 11% a year ago, leading to a 207% YoY surge in PAT to ₹345 crore. The company is successfully transitioning into an integrated nitrogen platform, with the ammonia-to-amines integration complete. Management confirmed that MIBK, MIBC, and Acetophenone projects are scheduled for commissioning in August 2026, which will further deepen downstream integration.
Confidence: HIGH
What changedDeepak Nitrite has transitioned from a nitration-focused company to an integrated nitrogen platform and is now moving into high-value downstream products like MIBK and MIBC.
Why it mattersThe shift towards downstream integration and the upcoming Polycarbonate project reduces reliance on commodity chemical cycles and improves structural cost competitiveness against global imports.
Q1 FY27 Revenue: ₹2,592 crQ1 PAT vs TTM PAT: 62.6%EBITDA Margin: 21%Phenolics EBIT Growth (YoY): 254%Advanced Intermediates Revenue: ₹804 cr
📅 Short termThe stock is likely to react positively to the record earnings and the immediate catalyst of new plant commissionings in August 2026.
📈 Long termThe company's strategy to build an integrated advanced material platform, including India's first integrated Polycarbonate project, positions it for structural growth and margin resilience over the next 3-5 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Global oversupply and dumping by Asian producers
- Volatility in feedstock prices (Propylene and Benzene)
- Execution risk for large-scale greenfield projects
Key Highlights
Consolidated Revenue reached ₹2,592 crore, up 35% YoY and 22% sequentially.
EBITDA hit an all-time high of ₹554 crore, with margins expanding to 21% from 11% in the previous year.
PAT for Q1 FY27 stood at ₹345 crore, which is approximately 62.6% of the total TTM PAT of ₹551 crore.
Phenolics segment delivered record EBIT of ₹418 crore, a 254% increase YoY.
Commissioning of MIBK, MIBC, and Acetophenone projects confirmed for August 2026.
👀 What to Watch
Investors should monitor the successful ramp-up of the MIBK and MIBC plants in Q2 FY27 and track the execution milestones of the large-scale Polycarbonate project. The sustainability of the 21% EBITDA margin amidst global chemical price volatility is a key metric to watch in upcoming quarters.
₹735 Cr Capex: Deepak Nitrite Commissions MIBK & MIBC Plant at Dahej
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has commissioned its Methyl Isobutyl Ketone (MIBK) and Methyl Isobutyl Carbinol (MIBC) plant at Dahej, Gujarat. The project involved a capital expenditure of approximately ₹735 Crores, which represents about 22.8% of the company's current net worth (₹3,215 Cr). This commissioning marks a significant move into downstream specialty chemicals, aiming to diversify the product mix and improve margin resilience against global dumping. The plant includes necessary offsite utilities and infrastructure, transitioning the project from the investment phase to the revenue-generation phase.
Confidence: HIGH
What changedThe company has successfully completed and commissioned a major ₹735 Cr downstream expansion project, moving from construction to production.
Why it mattersThis expansion into MIBK and MIBC reduces reliance on commodity chemicals and provides a hedge against global dumping by moving further down the value chain into specialty applications.
Project Capex: ₹735 CroresCapex vs Net Worth: ~22.8%Capex vs TTM Revenue: ~9.3%Commissioning Date: August 6, 2026
📅 Short termPositive sentiment is expected as the project begins contributing to the top line, potentially improving the revenue run rate from Q3 FY27 onwards.
📈 Long termStructurally significant as it strengthens the company's 'China+1' positioning and vertical integration, creating higher entry barriers in the specialty chemicals segment.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Ramp-up execution risk
- Global oversupply leading to pricing pressure
- Raw material price volatility
Key Highlights
Commissioned manufacturing operations for MIBK and MIBC at Dahej on August 6, 2026
Total capital expenditure incurred for the project is approximately ₹735 Crores
Capex represents ~9.3% of the company's TTM revenue of ₹7,887 Crores
Project executed through 100% subsidiary Deepak Chem Tech Limited
Includes integrated offsite utilities and infrastructure for the new facility
👀 What to Watch
Monitor the capacity utilization ramp-up and the resulting impact on consolidated operating margins (OPM) in the next 2-3 quarters. Investors should also watch for management commentary regarding domestic market share gains against imported MIBK/MIBC.
Deepak Nitrite Approves ₹7.50 Dividend and Key Leadership Elevations at 55th AGM
Deepak Nitrite concluded its 55th Annual General Meeting on August 5, 2026, where shareholders approved a dividend of ₹7.50 per share (375% of face value) for FY26. The meeting formalized significant leadership transitions, including the elevation of Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms. Additionally, Anant Pande was appointed as Executive Director & CMO, and Sanjay Upadhyay was re-appointed as Group CFO for another 5 years. These moves solidify the management structure as the company pursues its integrated Polycarbonate and downstream chemical projects.
Confidence: HIGH
What changedThe company has transitioned its leadership team with new Deputy MD roles and a dedicated CMO, while confirming the FY26 dividend payout.
Why it mattersManagement continuity and a clear leadership hierarchy are critical as the company manages a ₹23,720 Cr market cap and navigates global oversupply challenges in the chemical sector.
Dividend per share: ₹7.50Dividend % of Face Value: 375%Deputy MD Appointment Term: 5 yearsEstimated Dividend Payout: ~₹102 CrDividend vs TTM PAT: ~18.5%
📅 Short termThe stock is likely to react neutrally as the AGM proceedings and dividend were largely anticipated by the market.
📈 Long termThe 5-year mandates for the Deputy MDs and CFO provide structural stability for the company's long-term shift toward high-margin downstream products.
⚠ Risk flags
- Promoter remuneration levels (Special Resolution)
- Global oversupply impacting domestic margins
Key Highlights
Approved a dividend of ₹7.50 per equity share of ₹2.00 face value (375%) for FY26
Elevated Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms starting May 9, 2026
Appointed Anant Pande as Executive Director & CMO for a 3-year term effective August 5, 2026
Re-appointed Sanjay Upadhyay as Director (Finance) & Group CFO for a 5-year term from August 1, 2026
Approved the appointment of two new Independent Directors, Mitin Mehta and Adnan Ahmad, for 3-year terms
👀 What to Watch
Investors should monitor the final voting results to check for any significant dissent on promoter remuneration (Resolution 13). The focus remains on the execution timeline of the upcoming Polycarbonate and MIBK/MIBC projects mentioned in the company's growth strategy.
207% PAT Growth: Deepak Nitrite Reports Highest-Ever Quarterly Performance in Q1 FY27
Deepak Nitrite delivered a record-breaking Q1 FY27, with consolidated revenue growing 35% YoY to 2,592 Cr. Profitability saw a massive surge as PAT rose 207% YoY to 345 Cr, driven by a 254% EBIT jump in the Phenolics segment. The company is aggressively pursuing its 2,900 Cr Polycarbonate project, with equipment shipments from Germany already arriving at the Dahej site. EBITDA margins expanded significantly to 21.4% from 11.2% in the year-ago period, reflecting strong operational leverage.
Confidence: HIGH
What changedThe company has achieved a significant margin breakout, with EBITDA growing 159% YoY, moving past the margin compression seen in FY26.
Why it mattersThe record performance validates the company's vertical integration strategy and its ability to maintain high operating rates (Phenolics) despite global chemical industry volatility.
Q1 FY27 Revenue: 2,592 CrQ1 FY27 PAT: 345 CrPolycarbonate Project Commitment: 2,900 CrProject vs Market Cap: ~12.4%EBITDA Margin: 21.4%
📅 Short termThe stock is likely to react positively to the substantial earnings beat and the 'highest-ever' quarterly performance milestone.
📈 Long termStructural growth is underpinned by the 2,900 Cr downstream expansion into Polycarbonates, which aims to substitute imports and deepen the value chain.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical tensions affecting logistics costs
- Pricing uncertainty in chemical intermediates
- Execution risk for the large-scale Polycarbonate project
Key Highlights
Highest-ever quarterly revenue of 2,592 Cr, up 35% YoY and 22% QoQ
PAT surged 207% YoY to 345 Cr, significantly exceeding the TTM average quarterly run rate
Phenolics segment EBIT grew 254% YoY to 418 Cr, supported by favorable product spreads
Total financial commitment for the integrated Polycarbonate project reached 2,900 Cr
Renewable energy initiatives delivered 4.5 Cr in cost savings during the quarter
👀 What to Watch
Watch for the execution timeline of the 165,000 MT/yr Polycarbonate plant and the impact of the 15-year Petronet LNG agreement on long-term feedstock cost stability.
Rs 2,500 Cr Investment: Deepak Nitrite to Set Up 240 KTA Bisphenol A Plant
Deepak Nitrite's subsidiary, Deepak Chem Tech Limited (DCTL), has approved a major investment of approximately Rs 2,500 crore to establish a Bisphenol A (BPA) manufacturing plant. The project features a capacity of up to 240 KTA and includes greenfield infrastructure. This investment is highly significant, representing roughly 31.7% of the company's TTM revenue and 77.8% of its current net worth. The move completes a strategic value chain from Phenol/Acetone to Polycarbonate, aiming to capture growth in the Indian Epoxy resin market and captive requirements.
Confidence: HIGH
What changedDeepak Nitrite has formally committed to a large-scale downstream expansion into Bisphenol A, moving beyond its existing Phenolics business.
Why it mattersThis project creates a highly integrated chemical platform, reducing raw material risks for their upcoming Polycarbonate plant and entering the high-demand Epoxy resin market, which currently relies on imports.
Project Investment: Rs 2,500 CrCapacity: 240 KTAInvestment vs TTM Revenue: ~31.7%Investment vs Net Worth: ~77.8%Current Debt: Rs 60 Cr
📅 Short termThe market is likely to react positively to the scale of the expansion and the strategic move towards higher-value integrated products.
📈 Long termIf executed successfully, this transforms Deepak Nitrite into a dominant integrated player in the BPA-Polycarbonate chain, potentially improving long-term margins and market share.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk of a large-scale greenfield project
- Significant increase in debt levels
- Cyclicality of the Phenol-Acetone-BPA value chain
Key Highlights
Approved investment of approximately Rs 2,500 Crores for a new manufacturing complex.
Planned production capacity of up to 240 KTA for Bisphenol A (BPA).
Investment magnitude represents ~31.7% of TTM revenue (Rs 7,887 Cr).
Project to be funded through a mix of debt and equity, impacting the current low debt of Rs 60 Cr.
Enables a fully integrated value chain from Cumene to Polycarbonate resin.
👀 What to Watch
Watch for the finalization of detailed engineering and the specific debt-equity funding mix, as this will significantly alter the company's leverage profile from its current near-debt-free status.
Deepak Nitrite Appoints Lohit Shringi as CEO for Advanced Intermediates Business
Deepak Nitrite has appointed Shri Lohit Shringi as the Chief Executive Officer for its Advanced Intermediates (AI) business, effective August 4, 2026. Shringi brings over 27 years of experience, having previously served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. This leadership addition is strategic as the AI segment is currently undergoing both brownfield and greenfield expansions to deepen vertical integration. Given the company's TTM revenue of ‡7,887 Cr and current margin pressures from global dumping, this appointment aims to strengthen P&L management in a core growth area.
Confidence: HIGH
What changedThe company has transitioned the leadership of its Advanced Intermediates business to a dedicated CEO with extensive specialty chemicals experience.
Why it mattersThe Advanced Intermediates segment is central to Deepak Nitrite's 'China+1' strategy and downstream integration; professional leadership is vital to navigate current global oversupply and pricing challenges.
Leadership Experience: 27 yearsEffective Date: August 4, 2026TTM Revenue: ‡7,887 CrMarket Cap: ‡23,461 Cr
📅 Short termThe market is likely to view the addition of a seasoned industry veteran from PCBL and DuPont as a positive step for operational stability.
📈 Long termShringi's experience in specialty chemicals and global markets is structurally significant for the company's move into high-value downstream products like MIBK and Polycarbonates.
⚠ Risk flags
- Execution risk in ongoing greenfield projects
- Global oversupply impacting AI segment margins
Key Highlights
Shri Lohit Shringi appointed as CEO of Advanced Intermediates Business effective August 4, 2026.
Shringi brings over 27 years of leadership experience across P&L management and business transformation.
Previously held the role of Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited.
The AI segment is a critical driver for the company's ‡7,887 Cr TTM revenue base.
Appointment coincides with ongoing greenfield and brownfield expansions in the AI segment via DCTL.
👀 What to Watch
Investors should monitor the execution of the AI segment's expansion projects and margin recovery in upcoming quarterly results under the new leadership.
Deepak Nitrite Q1 FY27: Consolidated PAT Surges 207% YoY to ₹344.7 Cr
Deepak Nitrite reported a robust Q1 FY27 with consolidated revenue growing 36.4% YoY to ₹2,577.60 Cr. Net profit witnessed a massive jump of 207% YoY to ₹344.69 Cr, primarily driven by a sharp recovery in the Phenolics segment. The Phenolics segment EBIT rose 254% YoY to ₹417.76 Cr, while the Advanced Intermediates segment also grew revenue by 32.8% YoY. This performance represents a significant recovery from the margin pressures seen in previous quarters.
Confidence: HIGH
What changedDeepak Nitrite has reported a sharp turnaround in profitability for Q1 FY27, moving past the dumping-related margin compression seen in FY25/FY26.
Why it mattersThe strong performance in the Phenolics segment indicates improved domestic demand and better realization, providing the necessary cash flow for the company's massive downstream expansion plans.
Consolidated Revenue (Q1 FY27): ₹2,577.60 CrConsolidated PAT (Q1 FY27): ₹344.69 CrYoY PAT Growth: 207.1%Phenolics EBIT Margin: 23.5%Advanced Intermediates Revenue Growth: 32.8%
📅 Short termThe stock is likely to react positively in the short term due to the significant earnings beat and margin expansion in the Phenolics business.
📈 Long termThe long-term outlook remains tied to the successful operationalization of MIBK, MIBC, and the landmark Polycarbonate project, which will deepen vertical integration.
⚠ Risk flags
- Global oversupply and dumping by Asian producers
- Volatility in raw material and energy costs
- Execution risk on large-scale greenfield projects
Key Highlights
Consolidated Revenue from operations increased 36.4% YoY to ₹2,577.60 Cr from ₹1,889.88 Cr.
Consolidated Net Profit grew 207.1% YoY to ₹344.69 Cr compared to ₹112.25 Cr in the same quarter last year.
Phenolics segment EBIT jumped to ₹417.76 Cr from ₹117.90 Cr YoY, reflecting strong operating leverage.
Advanced Intermediates revenue grew to ₹803.85 Cr from ₹605.33 Cr in the year-ago period.
Government incentive income of ₹21.50 Cr was recognized during the quarter.
👀 What to Watch
Investors should monitor the sustainability of Phenolics margins and the execution timeline of the upcoming Polycarbonate project, which is key to long-term value creation.
₹120 Cr Investment in Deepak Chem Tech by Deepak Phenolics for Project Funding
Deepak Nitrite's subsidiary, Deepak Phenolics Limited (DPL), has invested ₹120 crore in another wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL). The investment is made through 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to support DCTL's project expenses and strengthen its capital base. DCTL is scaling rapidly, with its turnover increasing from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation supports the group's expansion into specialized segments like Fluorination and Nitric Acid.
Confidence: HIGH
What changedDeepak Nitrite has moved ₹120 crore of capital from its Phenolics subsidiary to its Chem Tech subsidiary to fund ongoing specialized chemical projects.
Why it mattersThis demonstrates the company's strategy of using cash flows from its established Phenolics business to fund high-growth, downstream specialized chemical segments without external debt.
Investment Amount: ₹120.00 CroresDCTL FY26 Turnover: ₹172.23 CroresInvestment vs Net Worth: ~3.7%OCRPS Coupon Rate: 9%DCTL FY25 Turnover: ₹9.43 Crores
📅 Short termNeutral, as this is an intra-group transaction with no immediate impact on consolidated financial performance.
📈 Long termPositive, as it facilitates the expansion of DCTL's specialized chemical portfolio, which is central to the company's long-term 'China+1' and import substitution strategy.
⚠ Risk flags
- Execution risk of ongoing projects within DCTL
- Cyclicality and global dumping risks in the chemical sector
Key Highlights
₹120 crore total investment through the allotment of 1,20,00,000 OCRPS at ₹100 each
DCTL turnover grew significantly to ₹172.23 crore in FY26 from just ₹9.43 crore in FY25
The 9% OCRPS are issued at par and represent an intra-group transaction on an arm's length basis
DCTL currently operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation in Gujarat
Deepak Nitrite continues to maintain 100% indirect control over DCTL's preference share capital
👀 What to Watch
Investors should monitor the operational ramp-up and margin profile of Deepak Chem Tech (DCTL) as it transitions from a project-phase entity to a meaningful revenue contributor.
$78.43 Million Corporate Guarantee Issued for Oman Subsidiary
Deepak Nitrite Limited has executed a Deed of Guarantee for US $78.43 million (approximately ₹655 crore) in favor of Bank Muscat SAOG. This guarantee secures a term loan for its 51% subsidiary, Deepak Oman Industries (SFZ) LLC (DOIL). The remaining 49% of DOIL is held by promoter entities, and the company will charge a guarantee commission for this service. This commitment represents a significant contingent liability, equivalent to approximately 20.4% of the company's current net worth.
Confidence: HIGH
What changedDeepak Nitrite has formally committed to backing a $78.43M loan for its Oman-based subsidiary, creating a new contingent liability.
Why it mattersThis move facilitates capital for the company's international expansion in Oman but links the parent company's balance sheet to the subsidiary's financial performance.
Guarantee Amount: US $78.43 MillionSubsidiary Ownership: 51%Guarantee vs Net Worth: ~20.4%Guarantee vs TTM Revenue: ~8.3%Parent Net Worth: ₹3,215 Cr
📅 Short termThe market is likely to view this as a routine support for a subsidiary, though the size of the contingent liability may be noted by analysts.
📈 Long termThe structural impact depends on the successful execution and profitability of the Oman project; failure there could impact the parent's credit profile.
⚠ Risk flags
- Contingent liability risk
- Related-party involvement (Promoters hold 49% of the subsidiary)
Key Highlights
Corporate guarantee of US $78.43 Million issued to Bank Muscat SAOG.
Guarantee supports a term loan for 51% subsidiary Deepak Oman Industries (SFZ) LLC.
Remaining 49% equity in the subsidiary is held by Promoter/Promoter entities.
The guarantee amount of ~₹655 crore represents 20.4% of the company's net worth of ₹3,215 crore.
The transaction is on an arm's length basis with a guarantee commission to be charged.
👀 What to Watch
Investors should monitor the operational progress and debt-servicing capability of the Oman subsidiary to ensure the guarantee is not invoked.
Deepak Nitrite Subsidiary DCTL Raises ₹120 Crore from Deepak Phenolics via OCRPS
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, has allotted 1.2 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary. The transaction, valued at ₹120 crore, is aimed at strengthening DCTL's capital base and funding its ongoing project expenses. DCTL is currently scaling its operations in Fluorination and Nitration, with its turnover jumping significantly from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation allows the group to utilize surplus funds from DPL to fuel growth in DCTL.
Key Highlights
DCTL allotted 1,20,00,000 9% OCRPS at a face value of ₹100 each, totaling ₹120 crore.
The investment was made by Deepak Phenolics Limited (DPL), a fellow wholly-owned subsidiary of Deepak Nitrite.
DCTL's turnover showed exponential growth, reaching ₹172.23 crore in FY 2025-26 compared to just ₹9.43 crore in FY 2024-25.
Funds will be utilized for project expenses across Fluorination, Nitric Acid, Nitration, and Hydrogenation plants in Gujarat.
The transaction was conducted at arm's length and does not change the parent company's 100% control over the subsidiaries.
👀 What to Watch
Investors should view this as a routine internal capital management move; however, the rapid turnover growth in DCTL suggests that the subsidiary's new projects are gaining traction and should be monitored for future consolidated earnings impact.
Deepak Nitrite Q4 FY26 PAT Surges 120% QoQ to ₹220 Cr; ₹7.5 Dividend Recommended
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with consolidated PAT rising 120% QoQ to ₹220 crore and EBITDA margins expanding significantly to 18% from 11% in Q3. The Phenolics segment was a major driver, achieving 20% EBIT margins despite global supply chain disruptions in the Middle East. For the full year FY26, the company recorded revenues of ₹7,947 crore and a PAT of ₹551 crore. Management confirmed that strategic projects including MIBK, MIBC, and the polycarbonate facility are on track, with some commissioning expected in Q2 FY27.
Key Highlights
Q4 FY26 EBITDA grew 74% sequentially to ₹383 crore, with margins improving to 18% from 11% in Q3.
Phenolics segment EBIT margins reached 20% in Q4, supported by stable plant operations and improving spreads.
Advanced Intermediates revenue grew 8% YoY to ₹708 crore, driven by stable domestic demand in India.
The Board recommended a final dividend of ₹7.5 per equity share for FY26.
Strategic MIBK and MIBC projects are scheduled for commissioning in Q2 FY27, enhancing future growth visibility.
👀 What to Watch
Investors should view the sharp sequential margin recovery as a positive sign of operational resilience. Monitor the timely commissioning of the MIBK and MIBC projects in Q2 FY27 as they are expected to further diversify the value-added product portfolio.
Deepak Nitrite Q4 FY26 PAT Jumps 120% Q-o-Q to ₹220 Cr; EBITDA Up 74% Sequentially
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with PAT rising 120% Q-o-Q to ₹220 crore and EBITDA growing 74% to ₹383 crore. While the full-year FY26 performance saw a 21% decline in PAT to ₹551 crore due to global pricing pressures, the quarterly momentum indicates a sharp turnaround in margins. The Phenolics segment delivered robust performance with a 97% Q-o-Q EBIT growth, supported by record production volumes. The company is also making significant progress on its Polycarbonate project and has established a new ₹100 crore R&D center to drive future growth.
Key Highlights
Q4 FY26 EBITDA grew 74% Q-o-Q to ₹383 crore, driven by proactive procurement and backward integration benefits.
Phenolics segment EBIT rose 97% Q-o-Q to ₹287 crore, achieving highest-ever production and sales in FY26.
Advanced Intermediates segment EBIT surged 125% Q-o-Q to ₹34 crore, aided by a favorable product mix.
Polycarbonate project on track with equipment shipments from Germany and a long-term HyCO plant agreement with Linde.
Maintained a strong dividend payout of 375% for FY26, including special and final dividends.
👀 What to Watch
Investors should take note of the significant sequential margin expansion and the company's successful navigation of global supply chain disruptions. The progress on the Polycarbonate project and the new R&D facility strengthen the long-term growth thesis for this chemical major.
Deepak Nitrite Appoints Anant Pande as ED & CMO; Re-appoints Girish Satarkar for 3 Years
Deepak Nitrite has announced a significant leadership transition with the appointment of Shri Anant Pande as Executive Director and Chief Manufacturing Officer for a three-year term starting August 5, 2026. Mr. Pande brings 40 years of extensive experience from leadership roles at Jubilant Life Sciences and Atul Limited. Concurrently, the board has approved the re-appointment of Shri Girish Satarkar as Executive Director for another three-year term. These changes come as Shri Ajay C. Mehta prepares to retire from the board at the upcoming Annual General Meeting.
Key Highlights
Shri Anant Pande appointed as Executive Director & Chief Manufacturing Officer for a 3-year term starting August 5, 2026
Shri Girish Satarkar re-appointed as Executive Director for a 3-year term effective August 4, 2026
Shri Ajay C. Mehta to retire from the Board at the ensuing AGM after not seeking re-appointment
New appointee Anant Pande has 40 years of experience in life sciences, chemicals, and pharmaceuticals
Girish Satarkar brings over 37 years of chemical industry experience to his continued role
👀 What to Watch
This is a routine succession and leadership strengthening move. Investors should monitor if the new Chief Manufacturing Officer introduces any operational efficiencies in the upcoming quarters.
Deepak Nitrite Recommends Final Dividend of ₹7.50 Per Share (375%) for FY2026
The Board of Directors of Deepak Nitrite Limited has recommended a final dividend of ₹7.50 per equity share for the financial year ended March 31, 2026. This represents a significant 375% payout on the face value of ₹2 per share. The dividend is applicable to over 13.63 crore equity shares and is subject to shareholder approval at the upcoming 55th Annual General Meeting. Upon approval, the payment will be processed within 30 days of the AGM date.
Key Highlights
Recommended final dividend of ₹7.50 per equity share for the year ended March 31, 2026
Dividend payout represents 375% of the face value of ₹2 per share
Total number of equity shares eligible for dividend stands at 13,63,93,041
Payment to be completed within 30 days from the date of the 55th Annual General Meeting
👀 What to Watch
Investors should monitor the announcement of the record date to ensure eligibility for the dividend. The healthy payout reflects the company's strong cash position and commitment to shareholder returns.
Deepak Nitrite Q4 FY26 Net Profit Jumps 103% YoY to ₹202.5 Cr Despite Annual Revenue Dip
Deepak Nitrite reported a strong recovery in Q4 FY26 with consolidated net profit doubling to ₹202.50 crore compared to ₹99.82 crore in the same quarter last year. For the full year FY26, consolidated revenue stood at ₹7,887.07 crore, a 4.8% decline from ₹8,281.93 crore in FY25, primarily due to lower realizations in the Phenolics segment. Annual net profit for FY26 settled at ₹610.21 crore, down from ₹697.37 crore in the previous year. Despite the annual decline, the sharp quarterly growth indicates significant margin improvement and operational recovery in the latter half of the year.
Key Highlights
Q4 FY26 Consolidated Net Profit surged 102.8% YoY to ₹202.50 crore.
Full-year FY26 Consolidated Revenue from operations stood at ₹7,887.07 crore vs ₹8,281.93 crore in FY25.
Phenolics segment revenue for FY26 decreased to ₹5,400.68 crore from ₹5,805.10 crore YoY.
Advanced Intermediates segment revenue remained resilient at ₹2,553.32 crore for FY26.
Consolidated Total Assets grew to ₹8,680.68 crore as of March 31, 2026, from ₹7,717.57 crore in the previous year.
👀 What to Watch
Investors should view the strong Q4 performance as a sign of cyclical recovery and margin expansion. While annual figures are lower, the sequential and YoY quarterly growth suggests the company is navigating pricing pressures effectively.
Deepak Nitrite Elevates Maulik Mehta to Deputy Managing Director for 5-Year Term
Deepak Nitrite has announced the elevation of Shri Maulik Mehta to the position of Deputy Managing Director, effective May 9, 2026. This appointment follows the completion of his tenure as Executive Director & CEO on May 8, 2026, and is set for a period of five years. Shri Mehta, who has 18 years of experience and an executive MBA from Harvard, is the son of the current Chairman and Managing Director, Deepak C. Mehta. The move is intended to ensure leadership continuity and drive the company's long-term 'Responsible Chemistry' and 'Depend on Deepak' strategic initiatives.
Key Highlights
Shri Maulik Mehta appointed as Deputy Managing Director for a 5-year term starting May 9, 2026
Mehta brings 18 years of experience in business development, product development, and ESG initiatives
Educational background includes an executive MBA from Harvard Business School and a Master's from Columbia University
The appointee is the son of Chairman Deepak C. Mehta, signaling clear succession planning and promoter commitment
Appointment is subject to the approval of the company's shareholders
👀 What to Watch
Investors should view this elevation as a sign of leadership stability and planned succession within the promoter family. No immediate portfolio changes are necessary as the transition appears seamless and maintains strategic continuity.
Deepak Nitrite Subsidiary Partners with Praxair India for HyCO Plant to Support Polycarbonate Project
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, has signed a long-term agreement with Praxair India (a Linde company) to build a HyCO plant. This facility will supply essential raw materials for DCTL's upcoming Polycarbonate manufacturing plant in Dahej, Gujarat. Under the agreement, Praxair will build, own, and operate the facility, ensuring a reliable feedstock supply for the project. The plant is expected to be commissioned in 2028, aligning with the timeline for the Polycarbonate project's launch.
Key Highlights
Long-term agreement with Praxair India (Linde) for a dedicated on-site HyCO plant at Dahej.
Secures critical raw material supply for the upcoming Polycarbonate manufacturing facility.
Facility to be built, owned, and operated by Praxair India, enhancing operational efficiency.
Commissioning of the HyCO plant is scheduled for 2028, matching the Polycarbonate plant's timeline.
Targets high-growth domestic segments including automotive, electronics, and construction.
👀 What to Watch
Investors should view this as a strategic de-risking move that secures the supply chain for a major growth project. Monitor the capital expenditure and execution progress of the Polycarbonate facility leading up to 2028.
Deepak Nitrite Subsidiary DCTL Raises ₹150 Cr from Deepak Phenolics via OCRPS
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL), has raised ₹150 Crores through the allotment of 1.5 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS). The funds were provided by Deepak Phenolics Limited (DPL), another wholly-owned subsidiary, representing an internal capital reallocation within the group. This infusion is designed to strengthen DCTL's capital base and support its ongoing project expenses in specialized segments like Fluorination and Nitration. DCTL is currently in a scaling phase, with turnover growing from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
Key Highlights
Allotment of 1,50,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each.
Total capital infusion of ₹150 Crores sourced internally from Deepak Phenolics Limited.
Funds targeted for project expenses and strengthening the capital base of DCTL's chemical operations.
DCTL's turnover showed significant growth to ₹9.43 Crores in FY 2024-25 from ₹0.86 Crores in FY 2023-24.
Post-allotment, Deepak Nitrite continues to maintain 100% effective control over DCTL.
👀 What to Watch
Investors should view this as a routine internal capital allocation to support the growth of a nascent subsidiary; focus should remain on the execution of DCTL's Fluorination and Nitration projects.
Deepak Nitrite Infuses ₹135 Cr into Subsidiary Deepak Chem Tech for Project Expansion
Deepak Nitrite (DNL) and its subsidiary Deepak Phenolics (DPL) have collectively invested ₹135 Crores into Deepak Chem Tech Limited (DCTL). The investment was made through the allotment of 1.35 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each. These funds are intended to strengthen DCTL's capital base and support its ongoing projects in Fluorination, Nitric Acid, and Nitration. DCTL is a growing subsidiary, with its turnover increasing from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
Key Highlights
Total capital infusion of ₹135 Crores into wholly-owned subsidiary Deepak Chem Tech Limited.
Issuance of 1.10 crore OCRPS to Deepak Phenolics and 25 lakh OCRPS to Deepak Nitrite at ₹100 par value.
Funds will support project expenses for Fluorination, Nitric Acid, Nitration, and Hydrogenation plants.
DCTL's turnover showed significant growth, reaching ₹9.43 Crores in FY 2024-25.
The 9% OCRPS are designed to provide flexible capital structure for the subsidiary's expansion in Gujarat.
👀 What to Watch
Investors should monitor the commissioning of DCTL's specialized chemical plants as they represent a key growth vertical for the group. The internal funding demonstrates the parent company's strong cash position and commitment to high-margin chemical segments.
